EP2329040 - MOLECULAR MARKERS FOR LUNG AND COLORECTAL CARCINOMAS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.08.2018 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 08.09.2017 | ||
Former | Grant of patent is intended Status updated on 25.04.2017 | ||
Former | Examination is in progress Status updated on 07.03.2017 | ||
Former | Grant of patent is intended Status updated on 28.02.2017 | ||
Former | Examination is in progress Status updated on 20.01.2017 | ||
Former | Grant of patent is intended Status updated on 07.12.2016 | Most recent event Tooltip | 03.07.2020 | Lapse of the patent in a contracting state New state(s): CY, MK | published on 05.08.2020 [2020/32] | Applicant(s) | For all designated states ADVPharma, Inc. 6F., No. 90, Sec. 1 Xintai 5th Rd. Xizhi Dist. New Taipei City 221 / TW | For all designated states Stason Pharmaceuticals, Inc. 11 Morgan Street Irvine, CA 92618-2005 / US | [2017/41] |
Former [2011/23] | For all designated states ADVPharma, Inc. 6F, No 90, Hsin-Tai Wu Road Sec. 1, His-Chih Town Taipei Hsien 221 / TW | ||
For all designated states Stason Pharmaceuticals, Inc. 11 Morgan Irvine, CA 92618-2005 / US | Inventor(s) | 01 /
TERNG, Harn-Jing 9F, No. 14 Lane 49 Guoguang Rd. Banciao City, 220 / TW | 02 /
LEE, Woan-Jen 2F, No. 1 Lane 27 Shueiyuan St. Yonghe City, 234 / TW | 03 /
CHEN, Chin-Yu 4F, No. 167 Fu 5th St. Qidu District Keelung City, 206 / TW | [2016/30] |
Former [2011/23] | 01 /
TERNG, Harn-Jing 9F, No. 14 Lane 49 Guoguang Rd. Banciao City 220 / TW | ||
02 /
LEE, Woan-Jen 2F, No. 1 Lane 27 Shueiyuan St. Yonghe City 234 / TW | |||
03 /
CHEN, Chin-Yu 4F, No. 167 Fu 5th St. Qidu District Keelung City 206 / TW | Representative(s) | Becker Kurig & Partner Patentanwälte mbB Bavariastraße 7 80336 München / DE | [N/P] |
Former [2017/41] | Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE | ||
Former [2011/23] | Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE | Application number, filing date | 09792084.7 | 28.08.2009 | [2011/23] | WO2009US55447 | Priority number, date | US20080099008P | 22.09.2008 Original published format: US 99008 P | [2011/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2010033371 | Date: | 25.03.2010 | Language: | EN | [2010/12] | Type: | A2 Application without search report | No.: | EP2329040 | Date: | 08.06.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.03.2010 takes the place of the publication of the European patent application. | [2011/23] | Type: | B1 Patent specification | No.: | EP2329040 | Date: | 11.10.2017 | Language: | EN | [2017/41] | Search report(s) | International search report - published on: | EP | 12.08.2010 | Classification | IPC: | C12Q1/68 | [2011/23] | CPC: |
C12Q1/6886 (EP,US);
C12Q2600/118 (EP,US);
C12Q2600/158 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2017/41] |
Former [2011/23] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Extension states | AL | Not yet paid | BA | Not yet paid | RS | Not yet paid | Title | German: | MOLEKULARE MARKER FÜR LUNGEN- UND KOLOREKTALKARZINOME | [2011/23] | English: | MOLECULAR MARKERS FOR LUNG AND COLORECTAL CARCINOMAS | [2011/23] | French: | MARQUEURS MOLÉCULAIRES POUR LES CARCINOMES PULMONAIRES ET COLORECTAUX | [2011/23] | Entry into regional phase | 19.01.2011 | National basic fee paid | 19.01.2011 | Designation fee(s) paid | 19.01.2011 | Examination fee paid | Examination procedure | 19.01.2011 | Examination requested [2011/23] | 31.01.2011 | Amendment by applicant (claims and/or description) | 27.06.2013 | Despatch of a communication from the examining division (Time limit: M04) | 24.10.2013 | Reply to a communication from the examining division | 06.10.2014 | Despatch of a communication from the examining division (Time limit: M04) | 06.02.2015 | Reply to a communication from the examining division | 17.06.2016 | Cancellation of oral proceeding that was planned for 22.06.2016 | 22.06.2016 | Date of oral proceedings (cancelled) | 30.06.2016 | Communication of intention to grant the patent | 11.10.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 08.12.2016 | Communication of intention to grant the patent | 19.01.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 01.03.2017 | Communication of intention to grant the patent | 06.03.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 26.04.2017 | Communication of intention to grant the patent | 22.08.2017 | Fee for grant paid | 22.08.2017 | Fee for publishing/printing paid | 22.08.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.06.2013 | Opposition(s) | 12.07.2018 | No opposition filed within time limit [2018/38] | Fees paid | Renewal fee | 26.08.2011 | Renewal fee patent year 03 | 31.08.2012 | Renewal fee patent year 04 | 29.08.2013 | Renewal fee patent year 05 | 19.08.2014 | Renewal fee patent year 06 | 27.07.2015 | Renewal fee patent year 07 | 01.08.2016 | Renewal fee patent year 08 | 31.08.2017 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 28.08.2009 | AT | 11.10.2017 | CY | 11.10.2017 | CZ | 11.10.2017 | DK | 11.10.2017 | EE | 11.10.2017 | ES | 11.10.2017 | FI | 11.10.2017 | HR | 11.10.2017 | IT | 11.10.2017 | LT | 11.10.2017 | LV | 11.10.2017 | MC | 11.10.2017 | MK | 11.10.2017 | NL | 11.10.2017 | PL | 11.10.2017 | PT | 11.10.2017 | RO | 11.10.2017 | SE | 11.10.2017 | SI | 11.10.2017 | SK | 11.10.2017 | SM | 11.10.2017 | TR | 11.10.2017 | BG | 11.01.2018 | NO | 11.01.2018 | GR | 12.01.2018 | IS | 11.02.2018 | [2020/31] |
Former [2020/27] | HU | 28.08.2009 | |
AT | 11.10.2017 | ||
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
IT | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
MC | 11.10.2017 | ||
NL | 11.10.2017 | ||
PL | 11.10.2017 | ||
PT | 11.10.2017 | ||
RO | 11.10.2017 | ||
SE | 11.10.2017 | ||
SI | 11.10.2017 | ||
SK | 11.10.2017 | ||
SM | 11.10.2017 | ||
TR | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2020/16] | AT | 11.10.2017 | |
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
IT | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
MC | 11.10.2017 | ||
NL | 11.10.2017 | ||
PL | 11.10.2017 | ||
RO | 11.10.2017 | ||
SE | 11.10.2017 | ||
SI | 11.10.2017 | ||
SK | 11.10.2017 | ||
SM | 11.10.2017 | ||
TR | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2019/15] | AT | 11.10.2017 | |
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
IT | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
MC | 11.10.2017 | ||
NL | 11.10.2017 | ||
PL | 11.10.2017 | ||
RO | 11.10.2017 | ||
SE | 11.10.2017 | ||
SI | 11.10.2017 | ||
SK | 11.10.2017 | ||
SM | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/52] | AT | 11.10.2017 | |
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
IT | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
NL | 11.10.2017 | ||
PL | 11.10.2017 | ||
RO | 11.10.2017 | ||
SE | 11.10.2017 | ||
SI | 11.10.2017 | ||
SK | 11.10.2017 | ||
SM | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/40] | AT | 11.10.2017 | |
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
IT | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
NL | 11.10.2017 | ||
PL | 11.10.2017 | ||
RO | 11.10.2017 | ||
SE | 11.10.2017 | ||
SK | 11.10.2017 | ||
SM | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/39] | AT | 11.10.2017 | |
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
IT | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
NL | 11.10.2017 | ||
PL | 11.10.2017 | ||
SE | 11.10.2017 | ||
SK | 11.10.2017 | ||
SM | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/37] | AT | 11.10.2017 | |
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
NL | 11.10.2017 | ||
PL | 11.10.2017 | ||
SE | 11.10.2017 | ||
SK | 11.10.2017 | ||
SM | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/35] | AT | 11.10.2017 | |
CZ | 11.10.2017 | ||
DK | 11.10.2017 | ||
EE | 11.10.2017 | ||
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
NL | 11.10.2017 | ||
SE | 11.10.2017 | ||
SK | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/24] | AT | 11.10.2017 | |
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
LT | 11.10.2017 | ||
LV | 11.10.2017 | ||
NL | 11.10.2017 | ||
SE | 11.10.2017 | ||
BG | 11.01.2018 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/23] | AT | 11.10.2017 | |
ES | 11.10.2017 | ||
FI | 11.10.2017 | ||
HR | 11.10.2017 | ||
LT | 11.10.2017 | ||
NL | 11.10.2017 | ||
SE | 11.10.2017 | ||
NO | 11.01.2018 | ||
GR | 12.01.2018 | ||
IS | 11.02.2018 | ||
Former [2018/22] | ES | 11.10.2017 | |
FI | 11.10.2017 | ||
LT | 11.10.2017 | ||
NL | 11.10.2017 | ||
NO | 11.01.2018 | ||
Former [2018/21] | FI | 11.10.2017 | |
LT | 11.10.2017 | ||
NL | 11.10.2017 | ||
NO | 11.01.2018 | ||
Former [2018/17] | NL | 11.10.2017 | Cited in | International search | [X]WO2008070616 (UNIV UTAH RES FOUND [US], et al) [X] 1-10,14-22 * claim 56, [235], [236], [244] and the whole document *; | [X]WO2008084219 (ONCOMETHYLOME SCIENCES SA [BE], et al) [X] 1-10,14-22 * abstract, p. 1, l. 1-25, and the whole document *; | [XI]WO2007013671 (ONCOTHERAPY SCIENCE INC [JP], et al) [X] 1-10,14-22 * abstract, [0056-0062], tab. 1-7 and the whole document, [0120]-[0123] * [I] 11,23-24,26; | [X]WO2007071053 (UNIV MONTREAL [CA], et al) [X] 26 * [0061] *; | [X] - CHENG MIN ET AL, "Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20080531), vol. 8, no. 1, ISSN 1471-2407, page 156, XP021034589 [X] 1-10,14-22 * abstract, p. 157, col. 2, p. 160, col. 2, p. 166, col. 1 and the whole document * | [A] - CHEN HSUAN-YU ET AL, "A five-gene signature and clinical outcome in non-small-cell lung cancer", NEW ENGLAND JOURNAL OF MEDICINE, MASSACHUSETTS MEDICAL SOCIETY, BOSTON, MA, US, (20070104), vol. 356, no. 1, ISSN 1533-4406, pages 11 - 20, XP009086044 [A] 1-11,14-24,26 * abstract, fig. 1 and the whole document * DOI: http://dx.doi.org/10.1056/NEJMoa060096 | [A] - FOURNIER MARCIA V ET AL, A strategy to identify genes associated with circulating solid tumor cell survival in peripheral blood, MOLECULAR MEDICINE (NEW YORK), VOL. 5, NR. 5, PAGE(S) 313-319, (199905), ISSN 1076-1551, XP002565929 [A] 1-11,14-24,26 * abstract, fig. 3 * | [A] - HAMPTON REGINA ET AL, "Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: Implication for the detection of circulating colon cancer cells", ONCOGENE, (20021107), vol. 21, no. 51, ISSN 0950-9232, pages 7817 - 7823, XP002565930 [A] 1-11,14-24,26 * abstract, p. 7817, col. 2 * DOI: http://dx.doi.org/10.1038/sj.onc.1205906 | Examination | WO2004048933 | - SLATTERY MARTHA L ET AL, "MAP kinase genes and colon and rectal cancer.", CARCINOGENESIS DEC 2012, (201212), vol. 33, no. 12, ISSN 1460-2180, pages 2398 - 2408 |